8 citations
,
April 2016 in “Experimental Dermatology”
The researchers reported that in mice, the type of tumor suppressor deleted along with oncogenic Kras activation in HFSCs influenced the specific squamous cell carcinoma phenotype that developed.
April 2023 in “Journal of Investigative Dermatology”
In this study, using a mouse model, researchers found that inducing senescence in hairfolliclestem cells led to hair regeneration failure and sebaceous gland enlargement, akin to androgenetic alopecia features.
In this study, conditional deletion of BRD4 in OX40-expressing cells of mice led to alopecia, dermatitis, and loss of hairfolliclestemcell function, revealing BRD4's role in skin inflammation and stemcell regulation.
Scientists discovered a sugar gel, 2dDR-SA, that increased hair growth in mice. Users discussed its potential, comparing it to other treatments like Minoxidil and finasteride.
PP405 may encourage earlier hair growth and slightly increase visible hair count but does not reverse hairfollicle miniaturization in male pattern baldness. It does not address damage to the dermal papilla or broken Wnt signaling.
Hair loss is influenced by genetics and sensitivity to hormones like DHT. Treatments like Minoxidil and finasteride are commonly used, and baldness persists as it doesn't affect reproductive success.
Prolactin may contribute to hair loss, but targeting its receptor won't cure androgenetic alopecia. ABS-201 could be a useful alternative or adjuvant therapy, similar to JAK inhibitors, but not more effective than HMI-115.
Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.
a signaling molecule from dermal papilla cells that activated hair growth in mice; not tested in people and not an approved treatment
What do clinical trials say about the safety and effectiveness of SCUBE3 for hair regrowth?No clinical trial of SCUBE3 for hair regrowth has been registered on ClinicalTrials.gov or published, so there is no human safety or effectiveness data. The evidence is limited to one 2022 laboratory and mouse study reporting that SCUBE3 activates hair follicle stem cells through TGF-beta signalling.
Can long-term use of Fluocinolone affect the health of hairfollicles?There is no long-term human trial measuring what topical fluocinolone does to hair follicles; what is documented is the label's warning about skin atrophy with prolonged use, plus a 2007 mouse study suggesting hair-follicle bulge stem cells do not repair steroid-induced atrophy.